Comparative Evaluation of Immunization with Recombinant Protein and Plasmid DNA Vaccines of Fusion Antigen ROP2 and SAG1 from Toxoplasma Gondii in Mice: Cellular and Humoral Immune Responses

Overview

Journal Parasitol Res

Specialty Parasitology

Date 2011 Mar 16

PMID 21404064

Citations 7

Authors

Wen-Shu Li

Qing-Xin Chen

Ju-Xiu Ye

Zi-Xin Xie

Jun Chen

Li-Fang Zhang

Affiliations

Soon will be listed here.

Abstract

The aim of this work was to evaluate immune responses in BALB/c mice vaccinated subcutaneously by recombinant protein, or intramuscularly by plasmid DNA with fusion antigen of rhoptry protein 2 (ROP2) and major surface protein 1 (SAG1) from Toxoplasma gondii (T. gondii). BALB/c mice were immunized with one of three different antigen formulations respectively, which were rROP2-SAG1, pcROP2-SAG1, and pcROP2-SAG1 boosted with rROP2-SAG1. The production of IgG, IgG subclasses, lymphoproliferation, and level of gamma interferon (IFN-γ) were detected after vaccination. The animals vaccinated with rROP2-SAG1 quickly developed specific anti-TLA (T. gondii lysate antigen) antibodies, which continued to rise after immunization. However, production of IgG against TLA in mice vaccinated with pcROP2-SAG1 was relatively slow and maintained a high level after reaching plateau. There are more vigorous specific lymphoproliferative responses observed in mice of group rROP2-SAG1 than in pcROP2-SAG1. Immune responses in mice of group pcROP2-SAG1 boosted with rROP2-SAG1 were similar to the protein immunization group. Three immunization procedures resulted in a similar level of IFN-γ production. Our results indicate that BALB/c mice vaccinated by three immunization procedures induce similar humoral and cellular immunity against infection of T. gondii. Mice immunized with recombinant protein rROP2-SAG1 produce more humoral immune responses than mice immunized with other antigen formulations.

Citing Articles

Toxoplasma gondii vaccine candidates: a concise review.

Javadi Mamaghani A, Fathollahi A, Arab-Mazar Z, Kohansal K, Fathollahi M, Spotin A Ir J Med Sci. 2022; 192(1):231-261.

PMID: 35394635 PMC: 8992420. DOI: 10.1007/s11845-022-02998-9.

Rhoptry antigens as vaccine target.

Foroutan M, Ghaffarifar F, Sharifi Z, Dalimi A, Jorjani O Clin Exp Vaccine Res. 2019; 8(1):4-26.

PMID: 30775347 PMC: 6369123. DOI: 10.7774/cevr.2019.8.1.4.

Identification of Antigenic and Immunogenic Proteins of Toxoplasma gondii in Human and Sheep by Immunoproteomics.

Ahady M, Hoghooghi-Rad N, Madani R, Esmaeili Rastaghi A Iran J Parasitol. 2018; 13(1):39-48.

PMID: 29963084 PMC: 6019589.

Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2).

Chen K, Wang J, Huang S, Yang W, Zhu W, Zhu X Parasite. 2017; 24:41.

PMID: 29119944 PMC: 5678354. DOI: 10.1051/parasite/2017045.

Vaccines against a Major Cause of Abortion in Cattle, Neospora caninum Infection.

Monney T, Debache K, Hemphill A Animals (Basel). 2015; 1(3):306-25.

PMID: 26486502 PMC: 4513463. DOI: 10.3390/ani1030306.

References

Tenter A, Heckeroth A, Weiss L . Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30(12-13):1217-58. PMC: 3109627. DOI: 10.1016/s0020-7519(00)00124-7. View

Saavedra R, Becerril M, Dubeaux C, Lippens R, de Vos M, Herion P . Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii. Infect Immun. 1996; 64(9):3858-62. PMC: 174303. DOI: 10.1128/iai.64.9.3858-3862.1996. View

Barnett S, Rajasekar S, Legg H, Doe B, Fuller D, Haynes J . Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine. 1997; 15(8):869-73. DOI: 10.1016/s0264-410x(96)00264-2. View

Fang R, Feng H, Nie H, Wang L, Tu P, Song Q . Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Vaccine. 2009; 28(7):1803-7. DOI: 10.1016/j.vaccine.2009.12.005. View

Letvin N, Montefiori D, Yasutomi Y, Perry H, Davies M, Lekutis C . Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci U S A. 1997; 94(17):9378-83. PMC: 23198. DOI: 10.1073/pnas.94.17.9378. View

Angus C, Dubey J, Kovacs J . Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis. 1999; 181(1):317-24. DOI: 10.1086/315186. View

Denkers E, Gazzinelli R . Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev. 1998; 11(4):569-88. PMC: 88897. DOI: 10.1128/CMR.11.4.569. View

Dlugonska H, Gatkowska J, Kur J, Gasior A . [The vaccines against toxoplasmosis--current status of the studies]. Wiad Parazytol. 2007; 53(3):195-201. View

Innes E, Vermeulen A . Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology. 2007; 133 Suppl:S145-68. DOI: 10.1017/S0031182006001855. View

10.

Rothel J, Waterkeyn J, Strugnell R, Wood P, Seow H, Vadolas J . Nucleic acid vaccination of sheep: Use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunol Cell Biol. 1997; 75(1):41-6. DOI: 10.1038/icb.1997.7. View

11.

Qian Z, Xuan B, Hong J, Hao Z, Wang L, Huang W . Expression and purification of the carboxyl terminus domain of Schizosaccharomyces pombe dicer in Escherichia coli. Protein Pept Lett. 2005; 12(4):311-4. DOI: 10.2174/0929866053765590. View

12.

Watkins D . HIV vaccine development. Top HIV Med. 2010; 18(2):35-6. View

13.

Leyva R, Herion P, Saavedra R . Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol Res. 2001; 87(1):70-9. DOI: 10.1007/s004360000296. View

14.

Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Dlugonska H . Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp Parasitol. 2009; 123(1):81-9. DOI: 10.1016/j.exppara.2009.06.002. View

15.

Echeverria P, de Miguel N, Costas M, Angel S . Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein. Vaccine. 2006; 24(19):4102-10. DOI: 10.1016/j.vaccine.2006.02.039. View

16.

Netzer W, Hartl F . Recombination of protein domains facilitated by co-translational folding in eukaryotes. Nature. 1997; 388(6640):343-9. DOI: 10.1038/41024. View

17.

Nielsen H, Lauemoller S, Christiansen L, Buus S, Fomsgaard A, Petersen E . Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun. 1999; 67(12):6358-63. PMC: 97042. DOI: 10.1128/IAI.67.12.6358-6363.1999. View

18.

Igarashi M, Kano F, Tamekuni K, Machado R, Navarro I, Vidotto O . Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice. Exp Parasitol. 2007; 118(3):386-92. DOI: 10.1016/j.exppara.2007.10.002. View

19.

Wang H, Liu Q, Liu K, Zhong W, Gao S, Jiang L . Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int. 2007; 56(4):263-8. DOI: 10.1016/j.parint.2007.04.003. View

20.

Li W, Lu H, Min T, Huang W . [Cloning and expression of the fused gene of rhoptry protein ROP2 and major surface protein P30 from Toxoplasma gondii]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2006; 23(6):415-8. View